This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ferrari, M. Articles by Figulla, H. R. Search for Related Content PubMed PubMed Citation Articles by Ferrari, M. Articles by Figulla, H. R.

Safety of deferring angioplasty in patients with normal coronary flow velocity reserve

^a Clinic of Internal Medicine III (Cardiology & Angiology & Intensive Care Medicine) Friedrich-Schiller-Universität, Jena, Germany
^* Clinic of Internal Medicine (Cardiology & Pulmonology) Georg-August-Universität, Göttingen, Germany

View larger version (15K): [in a new window]   Figure 1 Severity of angina pectoris (according to Canadian Cardiac Society) of patients who reported angina at stress before angioplasty, at discharge and after follow-up of 15 months. (n.s.: t test not significant).

View larger version (17K): [in a new window]   Figure 2 The slopes reflect the relation between risk of major adverse cardiac event (MACE: severe bleeding, re-PTCA, acute myocardial infarction, coronary bypass surgery, sudden cardiac death) and benefit (number of patients who are free of angina pectoris) in the PTCA subgroup (n = 48) and the non-PTCA subgroup (n = 22).